|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 106.64 CHF | -0.41% |
|
+2.28% | +20.23% |
| 12:59pm | AlphaValue/Baader Europe Ups Novartis Price Target on 'Strong' Execution, 'Vigorous' Growth | MT |
| 12:31pm | NOVARTIS AG : Upgraded to Buy by JP Morgan | ZD |
| Capitalization | 26TCr 22TCr 21TCr 19TCr 35TCr 23,00300Cr 39TCr 2,40300Cr 93TCr 10,86100Cr 96TCr 94TCr 39,79000Cr | P/E ratio 2025 * |
18.4x | P/E ratio 2026 * | 18.2x |
|---|---|---|---|---|---|
| Enterprise value | 28TCr 24TCr 22TCr 21TCr 38TCr 24,80100Cr 42TCr 2,59100Cr 1,00300Cr 11,71000Cr 1,03200Cr 1,01000Cr 42,90000Cr | EV / Sales 2025 * |
4.97x | EV / Sales 2026 * | 4.93x |
| Free-Float |
87.19% | Yield 2025 * |
3.07% | Yield 2026 * | 3.2% |
Last Transcript: Novartis AG
| 1 day | -0.49% | ||
| 1 week | +2.28% | ||
| Current month | +2.07% | ||
| 1 month | +4.34% | ||
| 3 months | +4.22% | ||
| 6 months | +9.30% | ||
| Current year | +20.23% |
| 1 week | 103.66 |  | 108.18 |
| 1 month | 99.45 | | 108.18 |
| Current year | 81.1 | | 108.18 |
| 1 year | 81.1 | | 108.18 |
| 3 years | 73.74 | | 108.18 |
| 5 years | 72.84 | | 108.18 |
| 10 years | 65.09 | | 108.18 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 49 | 01/02/2018 | |
| Director of Finance/CFO | 60 | 24/04/2013 | |
Shreeram Aradhye
CTO | Chief Tech/Sci/R&D Officer | 63 | 16/05/2022 |
| Director | Title | Age | Since |
|---|---|---|---|
Nancy Andrews
BRD | Director/Board Member | 66 | 01/01/2015 |
Liz Doherty
BRD | Director/Board Member | 68 | 01/01/2016 |
Ton Büchner
BRD | Director/Board Member | 60 | 01/01/2016 |
| Name | Weight | AuM | Varia. Jan 1. | Investor |
|---|---|---|---|---|
 | 10.4% | 121 M€ | -.--% | - |
| 5.57% | 26 M€ | +11.85% | - |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -0.41% | +2.28% | +19.31% | +25.02% | 26TCr | |
| -1.33% | -5.76% | +24.07% | +168.16% | 90TCr | |
| +0.44% | -1.43% | +35.29% | +14.22% | 49TCr | |
| -0.39% | +0.05% | +27.56% | +35.69% | 40TCr | |
| +2.19% | +2.82% | +23.52% | +4.87% | 33TCr | |
| -0.10% | -1.86% | +26.87% | +19.99% | 28TCr | |
| -0.22% | -2.43% | -4.27% | -10.37% | 25TCr | |
| -3.42% | -4.91% | -61.78% | -33.36% | 21TCr | |
| -1.62% | -3.88% | +16.85% | +13.60% | 18TCr | |
| +0.31% | -2.19% | +34.24% | +35.92% | 15TCr | |
| Average | -0.47% | -2.37% | +14.17% | +27.37% | 34.47TCr | |
| Weighted average by Cap. | -0.48% | -2.83% | +18.58% | +53.67% |
| 2025 * | 2026 * | |
|---|---|---|
| Net sales | 5.54TCr 4.77TCr 4.47TCr 4.16TCr 7.67TCr 4,99200Cr 8.37TCr 52TCr 20TCr 2,35700Cr 21TCr 20TCr 8,63600Cr | 5.66TCr 4.88TCr 4.58TCr 4.25TCr 7.84TCr 5,10700Cr 8.56TCr 53TCr 21TCr 2,41100Cr 21TCr 21TCr 8,83300Cr |
| Net income | 1.44TCr 1.24TCr 1.16TCr 1.08TCr 1.99TCr 1,29500Cr 2.17TCr 14TCr 5.24TCr 61TCr 5.39TCr 5.28TCr 2,24000Cr | 1.43TCr 1.23TCr 1.15TCr 1.07TCr 1.98TCr 1,28600Cr 2.16TCr 13TCr 5.2TCr 61TCr 5.36TCr 5.24TCr 2,22500Cr |
| Net Debt | 1.99TCr 1.72TCr 1.61TCr 1.5TCr 2.76TCr 1,79800Cr 3.01TCr 19TCr 7.27TCr 85TCr 7.49TCr 7.33TCr 3,11100Cr | 2.42TCr 2.08TCr 1.95TCr 1.82TCr 3.35TCr 2,17900Cr 3.65TCr 23TCr 8.81TCr 1,02900Cr 9.07TCr 8.88TCr 3,76900Cr |
| Date | Price | Change | Volume |
|---|---|---|---|
| 08/25/08 | 106.64 CHF | -0.41% | 30,19,489 |
| 05/25/05 | 107.08 CHF | +0.19% | 24,68,604 |
| 04/25/04 | 106.88 CHF | -0.48% | 22,85,780 |
| 03/25/03 | 107.40 CHF | +1.13% | 30,88,727 |
| 02/25/02 | 106.20 CHF | +1.86% | 31,37,431 |
Delayed Quote Swiss Exchange, December 08, 2025 at 10:01 pm IST
More quotes
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Global Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Global Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite), and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of the rankings based on the following ratings: Capital Efficiency (Composite), Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- NOVN Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition